Sale!

FLNA Gene Frontometaphyseal Dysplasia Genetic Test

4,400 د.إ

-21%

The FLNA Gene Frontometaphyseal Dysplasia Genetic Test is a specialized diagnostic procedure aimed at identifying mutations in the FLNA gene, which are responsible for Frontometaphyseal Dysplasia (FMD). FMD is a rare genetic disorder characterized by abnormalities in the development of the skeletal system and the muscles, leading to distinctive facial features, skeletal malformations, and other systemic complications. The FLNA gene plays a crucial role in cell structure and movement, and mutations in this gene can disrupt the normal development of bones and other tissues.

This genetic test involves analyzing the patient’s DNA to detect mutations in the FLNA gene that are indicative of Frontometaphyseal Dysplasia. It is a critical tool for confirming a diagnosis of FMD, enabling appropriate medical management and genetic counseling for affected individuals and their families.

The test is available at DNA Labs UAE, a leading provider of genetic testing services in the United Arab Emirates. The cost of the FLNA Gene Frontometaphyseal Dysplasia Genetic Test is 4400 AED. This comprehensive test is conducted under stringent quality control measures to ensure accurate and reliable results, providing essential information for the diagnosis and management of Frontometaphyseal Dysplasia.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

FLNA Gene Frontometaphyseal dysplasia Genetic Test

Components: Blood or Extracted DNA or One drop Blood on FTA Card

Price: 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test type: Neurological Disorders

Doctor: Neurologist

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for FLNA Gene Frontometaphyseal dysplasia NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with FLNA Gene Frontometaphyseal dysplasia.

Test Details

Frontometaphyseal dysplasia (FMD) is a rare genetic disorder that affects bone and cartilage development. It is caused by mutations in the FLNA gene, which provides instructions for making the protein filamin A. Filamin A helps to organize the cytoskeleton, which is the framework that gives cells their shape and helps them move.

NGS (next-generation sequencing) is a genetic test that can be used to analyze the FLNA gene and identify mutations that cause FMD. This test involves sequencing the entire FLNA gene, rather than just specific regions, which allows for a more comprehensive analysis of potential mutations.

NGS testing for FMD can help diagnose the condition in individuals with symptoms such as craniofacial abnormalities, skeletal abnormalities, and joint stiffness. It can also be used to identify carriers of the FLNA mutation in families with a history of FMD.

Genetic testing for FMD can provide valuable information for affected individuals and their families, including the potential for genetic counseling and management of symptoms. However, it is important to discuss the benefits and limitations of testing with a healthcare provider before undergoing any genetic testing.

Test Name FLNA Gene Frontometaphyseal dysplasia Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for FLNA Gene Frontometaphyseal dysplasia NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with FLNA Gene Frontometaphyseal dysplasia
Test Details

Frontometaphyseal dysplasia (FMD) is a rare genetic disorder that affects bone and cartilage development. It is caused by mutations in the FLNA gene, which provides instructions for making the protein filamin A. Filamin A helps to organize the cytoskeleton, which is the framework that gives cells their shape and helps them move.

NGS (next-generation sequencing) is a genetic test that can be used to analyze the FLNA gene and identify mutations that cause FMD. This test involves sequencing the entire FLNA gene, rather than just specific regions, which allows for a more comprehensive analysis of potential mutations.

NGS testing for FMD can help diagnose the condition in individuals with symptoms such as craniofacial abnormalities, skeletal abnormalities, and joint stiffness. It can also be used to identify carriers of the FLNA mutation in families with a history of FMD.

Genetic testing for FMD can provide valuable information for affected individuals and their families, including the potential for genetic counseling and management of symptoms. However, it is important to discuss the benefits and limitations of testing with a healthcare provider before undergoing any genetic testing.